| Combination of | |
|---|---|
| triamterene | antikaliuretic drug (potassium-sparing diuretic) |
| hydrochlorothiazide | diuretic/antihypertensive drug |
| Clinical data | |
| AHFS/Drugs.com | Consumer Drug Information |
| MedlinePlus | a601125 |
| Pregnancy cat. | C(US) |
| Legal status | ℞-only (US) |
| Routes | Oral |
| Identifiers | |
| ATC code | ? |
| (what is this?) (verify) |
|
Dyazide is the brand name for a drug marketed by GlaxoSmithKline used to treat hypertension (high blood pressure) and edema (water retention). Dyazide is a combination of triamterene and hydrochlorothiazide. This combination is in a class of medications called diuretics or 'water pills', and causes the kidneys to get rid of the body's unneeded water and sodium through the urine.[1]